Lou Basenese is Director at ENDRA Life Sciences Inc. (NDRA). They have made 6 open-market trades across 1 company since 2020, most recently 2026-01-21.
CIK 0001809482
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $42K since 2020, against 1 sale. Across 5 scored buys the stock is down 4.1% at ninety days, and 17.8 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NDRA | 65,709 | $325K |
Shares reported on the most recent Form 4, priced at the 2026-01-23 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 100% | 20% |
| Avg Move | +3.0% | +11.5% | -4.1% |
| Alpha | -0.7% | +10.8% | -17.8% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NDRA | SELL | 2021-08-25 | 2021-08-27 | $1.83 | $92K | -2.6% | -9.2% | -50.8% |
| NDRA | BUY | 2020-05-29 | 2020-06-01 | $0.90 | $9K | -6.6% | +2.2% | -9.9% |
| NDRA | BUY | 2020-05-28 | 2020-05-29 | $0.91 | $9K | +5.7% | +13.3% | -6.6% |
| NDRA | BUY | 2020-05-27 | 2020-05-28 | $0.85 | $9K | +5.3% | +13.3% | -6.6% |
| NDRA | BUY | 2020-05-26 | 2020-05-27 | $0.82 | $8K | +2.2% | +7.8% | -5.4% |
| NDRA | BUY | 2020-05-21 | 2020-05-22 | $0.71 | $7K | +8.1% | +20.9% | +8.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.